I have been enrolled in clinical trials for more than five years with great success. It can be scary, but as a scientist, I know more people like me need to participate. Future cancer developments will come from the evaluation of our data. It is very humbling to realize how important your data set is -- not only to you, but to the scientists and researchers who use it to improve the lives of so many others.  
 

We are fortunate that NYOH offers Phase I/II and Phase III clinical trials. I have friends and colleagues who participate in immunotherapy trials in Boston and New York City. The travel to and from treatments has added to the strain on them, as well as their families in balancing work and children.